To this aim we performed a case-cohort study within the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study including 101 children with CKD stages 3–5 treated with and without concomitant GH treatment. The gene discussed is GH1; the disease is chronic kidney disease.